Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Multiple Endocrine Neoplasia × Lansoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Zollinger-Ellison Syndrome 2 Stomach Ulcer 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia 1 Esophagitis, Peptic 1

Interventions

vandetanib 1 pertuzumab 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 Lansoprazole 1 Erlotinib Hydrochloride 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

University of Alabama at Birmingham

Phase 4 Completed

72 enrolled 8 charts

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡